Skip to main content

Molecular Diagnostics as Basis of Personalized Medicine

  • Chapter
  • First Online:
Textbook of Personalized Medicine

Abstract

Molecular diagnostics, the use of diagnostic testing to understand the molecular mechanisms of an individual patient’s disease, will be pivotal in the delivery of safe and effective therapy for many diseases in the future. Role of molecular diagnostics in personalized medicine covers the following aspects: Early detection and selection of appropriate treatment determined to be safe and effective on the basis of molecular diagnostics Integration of molecular diagnostics with therapeutics Monitoring therapy as well as determining prognosis

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Jain KK (2005) Personalised medicine for cancer – from drug development into clinical practice. Exp Opin Pharmacother 6:1463–1476

    Article  CAS  Google Scholar 

  • Jain KK (2007) Applications of nanobiotechnology in clinical diagnostics. Clin Chem 53:2002–2009

    Article  CAS  PubMed  Google Scholar 

  • Jain KK (2008) A handbook of nanomedicine. Springer/Human Press, Tatowa, NJ.

    Google Scholar 

  • Jain KK (2009a) Molecular diagnostics: technologies, markets and companies. Jain PharmaBiotech, Basel, Switzerland.

    Google Scholar 

  • Jain KK (2009b) DNA sequencing: technologies, markets and companies. Jain PharmaBiotech, Basel, Switzerland.

    Google Scholar 

  • Jain KK (2009c) Biochips/microarrays: technologies, markets and companies. Jain PharmaBiotech, Basel, Switzerland.

    Google Scholar 

  • Jain KK (2009d) Nanobiotechnology: applications, markets and companies. Jain PharmaBiotech, Basel, Switzerland.

    Google Scholar 

  • Jain KK (2009e) Proteomics: technologies, markets and companies. Jain PharmaBiotech, Basel, Switzerland.

    Google Scholar 

  • Jain KK (2009n) Cytogenetics: technologies, markets and companies. Jain PharmaBiotech, Basel, Switzerland.

    Google Scholar 

  • Lin M, Aquilante C, Johnson JA, Wu R (2005) Sequencing drug response with HapMap. Pharma-cogenomics J 5:149–156

    Article  CAS  PubMed  Google Scholar 

  • Manolio TA, Brooks LD, Collins FS (2008) A HapMap harvest of insights into the genetics of common disease. J Clin Invest 118:1590–1605

    Article  CAS  PubMed  Google Scholar 

  • Valet G (2005) Cytomics, the human cytome project and systems biology: top-down reso-lution of the molecular biocomplexity of organisms by single cell analysis. Cell Prolif 38:171–174

    Article  CAS  PubMed  Google Scholar 

  • Zhang J, Lang HP, Huber F et al (2006) Rapid and label-free nanomechanical detection of biomarker transcripts in human RNA. Nat Nanotechnol 1:214–220

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kewal K. Jain .

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Jain, K.K. (2009). Molecular Diagnostics as Basis of Personalized Medicine. In: Textbook of Personalized Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0769-1_2

Download citation

Publish with us

Policies and ethics